← Back to patent-cliff list
CAS 1001054-27-8
((2R,3S,4R,5R)-3-acetoxy-5-(2-amino-6-methoxy-9H-purin-9-yl)-4-hydroxytetrahydrofuran-2-yl)methyl acetate
Codes: NELA-007
Application context (from source-drug indications)
T-lymphoblastic lymphoma/leukaemiaNelarabineSézary syndromeNelarabineMarginal zone B-cell lymphomaNelarabineAdult T-cell leukaemia/lymphomaNelarabineWaldenström macroglobulinaemiaNelarabineLymphomaNelarabine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Nelarabine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(2R,3R,4S,5R)-2-(2-amino-6-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol→(2R,3R,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol→(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(2-amino-6-methoxy-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate→((2R,3S,4R,5R)-3-acetoxy-5-(2-amino-6-methoxy-9H-purin-9-yl)-4-hydroxytetrahydrofuran-2-yl)methyl acetate→((2R,3R,4R,5R)-3-acetoxy-5-(2-amino-6-methoxy-9H-purin-9-yl)-4-(((trifluoromethyl)sulfonyl)oxy)tetrahydrofuran-2-yl)methyl acetate→(2R,3R,4S,5R)-2-(acetoxymethyl)-5-(2-amino-6-methoxy-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.